Chrysosplenetin inhibits artemisinin efflux in P-gp-over-expressing Caco-2 cells and reverses P-gp/MDR1 mRNA up-regulated expression induced by artemisinin in mouse small intestine

References

• Alcantara LM, Kim J, Moraes CB, Franco CH, Franzoi KD, Lee S, Freitas-Junior LH, Ayong LS. 2013. Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites. Exp Parasitol. 134:235–243.
   PubMed Web of Science ®Google Scholar
• Burk O, Arnold KA, Nussler AK, Schaeffeler E, Efimova E, Avery BA, Avery MA, Fromm MF, Eichelbaum M. 2005. Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol. 67:1954–1965.
   PubMed Web of Science ®Google Scholar
• Chen J, Li N, Wu XL, Liu C, Fan YR, Huang Y, Yu JQ, Bai CC, Han L, Fu XY, et al. 2014. *The method to purify three polymethoxylated flavonoids from the industrial waste. China Patent no. ZL201210093926.0.
   Google Scholar
• Chieli E, Romiti N, Catiana Zampini I, Garrido G, Inés Isla M. 2012. Effects of Zuccagnia punctata extracts and their flavonoids on the function and expression of ABCB1/P-glycoprotein multidrug transporter. J Ethnopharmacol. 144:797–801.
   PubMed Web of Science ®Google Scholar
• Collett A, Tanianis-Hughes J, Warhurst G. 2004. Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions? Biochem Pharmacol. 68:783–790.
   PubMed Web of Science ®Google Scholar
• Daddam JR, Dowlathabad MR, Panthangi S, Jasti P. 2014. Molecular docking and P-glycoprotein inhibitory activity of flavonoids. Interdiscip Sci. 6:167–175.
   PubMed Web of Science ®Google Scholar
• Grybauskas A, Koga T, Kuprys PV, Nolan M, McCarty R, Walker L, Green KA, Norkett WM, Yue BY, Knepper PA. 2015. ABCB1 transporter and toll-like receptor 4 in trabecular meshwork cells. Mol Vis. 21:201–212.
   PubMed Web of Science ®Google Scholar
• Hao S, Xiao Y, Lin Y, Mo ZT, Chen Y, Peng XF, Xiang CH, Li YQ, Li WN. 2016. Chlorogenic acid-enriched extract from Eucommia ulmoides leaves inhibits hepatic lipid accumulation through regulation of cholesterol metabolism in HepG2 cells. Pharm Biol. 54:251–259.
   PubMed Web of Science ®Google Scholar
• Hu PY, Liu D, Zheng Q, Wu Q, Tang Y, Yang M. 2016. Elucidation of transport mechanism of paeoniflorin and the influence of ligustilide, senkyunolide I and senkyunolide A on paeoniflorin transport through Mdck-Mdr1 cells as blood-brain barrier in vitro model. Molecules. 21:1–13.
   Web of Science ®Google Scholar
• Inami M, Fukushima A, Ueno T, Yamada T, Tsunemi A, Matsumoto Y, Fukuda N, Soma M, Moriyama M. 2015. Reduction of dimethylnitrosamine-induced liver fibrosis by the novel gene regulator PI polyamide targeting transforming growth factor β1 gene. Biol Pharm Bull. 38:1836–1842.
   PubMed Web of Science ®Google Scholar
• Li Y, Revalde JL, Reid G, Paxton JW. 2010. Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer. Drug Metab Rev. 42:590–611.
   PubMed Web of Science ®Google Scholar
• Meng X, Liao S, Wang XY, Wang SX, Zhao XF, Jia P, Pei WJ, Zheng XP, Zheng XH. 2014. Reversing P-glycoprotein-mediated multidrug resistance in vitro by α-asarone and β-asarone, bioactive cis–trans isomers from Acorus tatarinowii. Biotechnol Lett. 36:685–691.
   PubMed Web of Science ®Google Scholar
• Meshnick SR, Taylor TE, Kamchonwongpaisan S. 1996. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev. 60:301–315.
   PubMedGoogle Scholar
• Miao Q, Wang ZY, Zhang YY, Miao PP, Zhao YY, Zhang YJ, Ma SC. 2016. In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs. Pharm Biol. 25:1–9.
   Google Scholar
• Middleton E Jr, Kandaswami C, Theoharides TC. 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 52:673–751.
   PubMed Web of Science ®Google Scholar
• Mohseni M, Samadi N, Ghanbari P, Yousefi B, Tabasinezhad M, Sharifi S, Nazemiyeh H. 2016. Co-treatment by docetaxel and vinblastine breaks down P-glycoprotein mediated chemo-resistance. Iran J Basic Med Sci. 19:300–309.
   PubMed Web of Science ®Google Scholar
• Nabekura T, Hiroi T, Kawasaki T, Uwai Y. 2015. Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein. Biomed Pharmacother. 70:140–145.
   PubMed Web of Science ®Google Scholar
• Numonov SR, Qureshi MN, Aisa HA. 2015. Development of HPLC protocol and simultaneous quantification of four free flavonoids from Dracocephalum heterophyllum Benth. Int J Anal Chem. 2015:1–5.
   Web of Science ®Google Scholar
• Pal D, Kwatra D, Minocha M, Paturi DK, Budda B, Mitra AK. 2011. Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals. Life Sci. 88:959–971.
   PubMed Web of Science ®Google Scholar
• Sandor V, Fojo T, Bates SE. 1998. Future perspectives for the development of P-glycoprotein modulators. Drug Resist Update. 1:190–200.
   PubMed Web of Science ®Google Scholar
• Sun RJ, Zeng M, Du T, Li L, Yang GY, Hu M, Gao S. 2015. Simultaneous determinations of 17 marker compounds in Xiao-Chai-Hu-Tang by LC-MS/MS: application to its pharmacokinetic studies in mice. J Chromatogr B Anal Technol Biomed Life Sci. 1003:12–21.
   PubMed Web of Science ®Google Scholar
• Suri S, Taylor MA, Verity A, Tribolo S, Needs PW, Kroon PA, Hughes DA, Wilson VG. 2008. A comparative study of the effects of quercetin and its glucuronide and sulfate metabolites on human neutrophil function in vitro. Biochem Pharmacol. 76:645–653.
   PubMed Web of Science ®Google Scholar
• Tripathi R, Rizvi A, Pandey SK, Dwivedi H, Saxena JK. 2013. Ketoconazole, a cytochrome P450 inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis. Acta Trop. 126:150–155.
   PubMed Web of Science ®Google Scholar
• Wang XM, Zhang X, Huang XH, Li YT, Wu MC, Liu JF. 2015. The drug–drug interaction of sorafenib mediated by P-glycoprotein and CYP3A4. Xenobiotica. 18:1–8.
   Google Scholar
• Wei SJ, Ji HY, Yang B, Ma LP, Bei ZC, Li X, Dang HW, Yang XY, Liu C, Wu XL, et al. 2015. Impact of chrysosplenetin on the pharmacokinetics and anti-malarial efficacy of artemisinin against Plasmodium berghei as well as in vitro CYP450 enzymatic activities in rat liver microsome. Malar J. 14:1–13.
   PubMed Web of Science ®Google Scholar
• Wesolowska O. 2011. Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1. Acta Biochim Pol. 58:433–448.
   PubMed Web of Science ®Google Scholar
• White NJ. 2004. Antimalarial drug resistance. J Clin Invest. 113:1084–1092.
   PubMed Web of Science ®Google Scholar
• Xia CQ, Milton MN, Gan LS. 2007. Evaluation of drug-transporter interactions using in vitro and in vivo models. Curr Drug Metab. 8:341–363.
   PubMed Web of Science ®Google Scholar
• Yuan J, Wong IL, Jiang T, Wang SW, Liu T, Wen BJ, Chow LM, Wan Sheng B. 2012. Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells. Eur J Med Chem. 54:413–422.
   PubMed Web of Science ®Google Scholar
• Zhang XW, Bu P, Liu L, Zhang XZ, Li J. 2015. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance. Biochem Biophys Res Commun. 462:227–232.
   PubMed Web of Science ®Google Scholar